Holland Johnson

Boston Sci swings for the fences with $14.5B Penumbra buy Boston Scientific Corp. looked ready to keep steamrolling down the acquisition path, carrying the momentum from last year, with the news that it is acquiring Penumbra Inc., a company that makes devices for interventional therapies to treat vascular conditions such as stroke and aneurysm, for a whopping $14.5 billion. BioWorld MedTech Deals and M&A Cardiovascular U.S.

J.P. Morgan Healthcare Conference Illumina Billion Cell Atlas to accelerate AI, drug discovery Illumina Inc. presented at the J.P. Morgan 2026 Healthcare Conference on Jan. 13 and introduced what it said is the world's largest genome-wide genetic perturbation dataset, being built to accelerate drug discovery through AI across the pharmaceutical ecosystem. This is a move away from its core focus on DNA sequencing technology.

Edwards scraps Jenavalve buy in face of FTC objections Edwards Lifesciences Corp. said it is scrapping plans to acquire Jenavalve Technology Inc. for $945 million after a federal court ruled against the company in a case brought by the U.S. Federal Trade Commission (FTC) to block the deal. BioWorld MedTech Deals and M&A Cardiovascular U.S. FTC